Presentation TCT 2025 TCT 735: Three-year clinical outcomes of transcatheter left atrial appendage occlusion Presenter: Chao Gao October 28, 2025 REGISTER for free or LOG IN to view this content TCT 2025 Up Next Presentation TCT 2025 TCT 736: Cost Effectiveness Analysis of the OPTION Trial: Left Atrial Appendage Closure after Ablation for Non-Valvular Atrial Fibrillation Presenter: Devi G. Nair October 28, 2025 More slides + Presentation TCT 2025 TCT 1049: Escalating Mortality from Pulmonary Embolism in U.S Women of Reproductive Age: A Retrospective Analysis (1999–2020) with Projections to 2030 Presenter: Anum Ijaz October 28, 2025 Presentation TCT 2025 TCT 850: The Continuous Saline Infusion Rate Required to Achieve Maximal Hyperaemia for Catheter-Based Measurements of Absolute Coronary Blood Flow and Microcirculatory Resistance in Severe Aortic Stenosis – The CORFLO-AS Validate Trial Presenter: Harsh V. Thakkar October 28, 2025 We Recommend Disclosures <p>Nothing to disclose</p>
Presentation TCT 2025 TCT 736: Cost Effectiveness Analysis of the OPTION Trial: Left Atrial Appendage Closure after Ablation for Non-Valvular Atrial Fibrillation Presenter: Devi G. Nair October 28, 2025
Presentation TCT 2025 TCT 1049: Escalating Mortality from Pulmonary Embolism in U.S Women of Reproductive Age: A Retrospective Analysis (1999–2020) with Projections to 2030 Presenter: Anum Ijaz October 28, 2025
Presentation TCT 2025 TCT 850: The Continuous Saline Infusion Rate Required to Achieve Maximal Hyperaemia for Catheter-Based Measurements of Absolute Coronary Blood Flow and Microcirculatory Resistance in Severe Aortic Stenosis – The CORFLO-AS Validate Trial Presenter: Harsh V. Thakkar October 28, 2025